Navigation Links
Human error most common cause of birth asphyxia
Date:11/17/2013

Findings from a 15-year study published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, indicate that human error is the most common cause of infant asphyxiation at birth. Inadequate fetal monitoring, lack of clinical skills, and failure to obtain senior medical staff assistance are most often cited in Norwegian compensation claims following birth asphyxia.

In Norway there are roughly 60,000 births each year, with The Norwegian System of Compensation to Patients (NPE) receiving 65 claims for obstetric injury to the child. A previous study by the current research team found that asphyxia was the most common cause for compensationbetween 20 and 25 cases annually. Prior research estimate that lifelong compensation for injury caused by birth asphyxia averages about 430,000 ($574,000) in Norway, with costs more than 10 times higher in the U.S.

"While fetal brain injury or death is uncommon during childbirth, when it occurs the effects are devastating," explains Dr. Stine Andreasen with the Department of Obstetrics and Gynecology at Nordlandssykehuset (Nordland Hospital) in Bod, Norway. "Our study investigates claims made to the NPE for neurological injury or death following birth asphyxia."

For the present study, researchers examined 315 claims made to the NPE between 1994 and 2008 that were associated with alleged birth asphyxia. The team looked at hospital records, assessments by experts, along with NPE and courts of law decisions. Of the claims made, there were 161 cases that were awarded compensation.

Results show that in the compensated cases there were 107 infants who survived, with 96 having neurological injury, and 54 children who died. Human error was the most common cause of birth asphyxia with 50% attributed to inadeuate fetal monitoring, 14% lack of clinical knowledge, 11% non-compliance to clinical guidelines, 10% failure to ask
'/>"/>

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ancient, modern DNA tell story of first humans in the Americas
2. Human stem cells used to elucidate mechanisms of beta-cell failure in diabetes
3. Fast-mutating DNA sequences shape early development; guided evolution of uniquely human traits
4. S14G-humanin is a new hope for Alzheimers disease
5. HIV -- Geneticists map human resistance to AIDS
6. Study maps human impacts on top ocean predators along US west coast
7. Induced pluripotent stem cells reveal differences between humans and great apes
8. Rats! Humans and rodents process their mistakes
9. Baculovirus-recognizing human cell receptor identified for the first time
10. New approach to treating human brain cancer could lead to improved outcomes
11. Superconductivity to meet humanitys greatest challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
(Date:2/5/2015)... 27, 2015   Marvin Test Solutions ... innovative test solutions for military, aerospace, and ... its TS-323 GENASYS Test Platform ... GENASYS is a high-performance PXI-based system designed ... that require performance functional testing. GENASYS features ...
(Date:2/5/2015)... 2015  It is gratifying to see that the ... genomic science as a means to better understand human ... I was honored to participate in today,s White House ... Since the 1980s my teams have ... first sequenced genome of a free living organism, the ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
... clinical study, researchers administered a new method for treating ... be worn like a band-aid. The applicator delivers low-frequency, ... significantly accelerate healing in five patients with venous ulcers. ... malfunction, causing blood to pool in the leg instead ...
... Calif.) Chanel, UC Santa Barbara,s corpse flower, has finally ... a cross between rotting flesh and Limburger cheese. "It,s disgusting," ... pretty nasty." Other visitors said Chanel smelled like "French ... a computer technician in the Life Science Computing Group at ...
... on a fatal case of potato poisoning: James B. Matheney ... bushels of tubers, which had turned green due to sunlight ... family -- wife, two daughters and four sons -- showed ... didn,t eat the potatoes, and a breast-fed baby boy. His ...
Cached Biology News:Ultrasound patch heals venous ulcers in human trial 2Ultrasound patch heals venous ulcers in human trial 3Ultrasound patch heals venous ulcers in human trial 4Chanel, UCSB's corpse flower, blooms and causes a big stink 2Chanel, UCSB's corpse flower, blooms and causes a big stink 3The pathway to potato poisons 2
(Date:3/5/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ... Biotech Outlook 2015: New Therapy Ventures Pave the Way ... All biotech companies - Gilead (GILD), Amgen (AMGN), ... have given a positive return and hence increased the ... to select therapy/niche indication where the high treatment cost ...
(Date:3/5/2015)... 05, 2015 RMI ... chronic orthopedic conditions such as meniscal tears, ACL ... and joint pain due to degenerative conditions like ... orthopedic surgeries to promote better post-surgical outcomes. , ... nearly pain-free bone marrow harvesting with two complimentary ...
(Date:3/4/2015)... 2015  Brooklyn residents now have a new place ... and injuries. Nunzio Saulle , M.D., a board-certified ... his NJS Physical Medicine and Rehabilitation (PM&R) practice in ... 5, 2015. Health Plus Management, LLC is managing the ... 1178 Flatbush Avenue. This new PM&R practice will treat ...
(Date:3/4/2015)... March 4, 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) ... completed a collaborative research program with Emerald ... Fast Collective Evolution Technology (FACET), Emerald Logic ... measurements obtained from each of 798 patients ... clinical trials ASSERT, SUSTAIN and ASSURE. The ...
Breaking Biology Technology:Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4
... 13 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... Global Pharmaceutical, Biotech and Medtech Conference,will be webcast ... Investors section,of the Company,s website, http://www.millennium.com . ... presentation will include an overview of the Company, ...
... Cephalon, Inc. (Nasdaq:,CEPH) today communicated with ... dosing and administration for FENTORA(R),(fentanyl buccal tablet) ... the medical community to reinforce the appropriate ... letter, issued in collaboration with the U.S. ...
... Technology Symposium Brings Together Thought Leaders,in Life Sciences ... Practices, OOSTERHOUT, Netherlands, Sept. 13 Luminex,Corporation ... multiplexed solutions,today announced the agenda for Planet xMAP ... The two-day event will be,held 2-3 October at ...
Cached Biology Technology:Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation 2Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 2Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 3Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 4Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 5Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium 2Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium 3
... high quality whole genome sequencing service. Our ... allow even the smallest of laboratories to ... features which set our whole genome sequencing ... strategies, proprietary assembly software, rapid project turnaround ...
Sequencing and primer design rolled into one. Just give us your clone and a reference sequence, and we'll do the rest. Single-strand or double-strand coverage. Guaranteed results....
...
... Mynox is the first biological ... killing them, and not just ... the only anti-mycoplasma agent that ... virus stocks directly. The cytotoxicity ...
Biology Products: